MENU
+Compare
GENW
ETF ticker: NYSE ARCA
AS OF
Nov 19, 11:54 AM (EDT)
Price
$12.52
Change
-$0.07 (-0.56%)

GENW stock forecast, quote, news & analysis

The investment seeks current income and long-term capital appreciation... Show more

GENW
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for GENW with price predictions
Nov 18, 2025

GENW's RSI Indicator recovers from overbought zone

The 10-day RSI Oscillator for GENW moved out of overbought territory on November 17, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 12 instances where the indicator moved out of the overbought zone. In of the 12 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 9 cases where GENW's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GENW declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GENW broke above its upper Bollinger Band on November 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 06, 2025. You may want to consider a long position or call options on GENW as a result. In of 8 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for GENW just turned positive on November 10, 2025. Looking at past instances where GENW's MACD turned positive, the stock continued to rise in of 6 cases over the following month. The odds of a continued upward trend are .

GENW moved above its 50-day moving average on November 06, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for GENW crossed bullishly above the 50-day moving average on October 28, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 1 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GENW advanced for three days, in of 25 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 59 cases where GENW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN), BP plc (NYSE:BP), Barclays PLC (NYSE:BCS), Ericsson (NASDAQ:ERIC).

Industry description

The investment seeks current income and long-term capital appreciation. Under normal market conditions, the fund will invest at least 80% of its assets plus borrowings for investment purposes in foreign equity securities that have records of paying dividends. In addition, the fund will invest in a diversified portfolio of 25 to 50 securities typically spread across many economic sectors.

Market Cap

The average market capitalization across the Genter Capital International Div ETF ETF is 91.95B. The market cap for tickers in the group ranges from 20.23B to 276.48B. AZN holds the highest valuation in this group at 276.48B. The lowest valued company is NMR at 20.23B.

High and low price notable news

The average weekly price growth across all stocks in the Genter Capital International Div ETF ETF was 2%. For the same ETF, the average monthly price growth was 10%, and the average quarterly price growth was 38%. SMFG experienced the highest price growth at 2%, while ABBNY experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Genter Capital International Div ETF ETF was 24%. For the same stocks of the ETF, the average monthly volume growth was 8% and the average quarterly volume growth was 169%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 37
Price Growth Rating: 48
SMR Rating: 63
Profit Risk Rating: 28
Seasonality Score: 30 (-100 ... +100)
View a ticker or compare two or three
GENW
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category ForeignLargeValue

Profile
Fundamentals
Details